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Abstract—Mathematical models for the regulation of the
Ca
2+-dependent transcription factors NFAT and NFjB that
are involved in the activation of the immune and inﬂamma-
tory responses in T lymphocytes have been developed. These
pathways are important targets for drugs, which act as
powerful immunosuppressants by suppressing activation of
NFAT and NFjB in T cells. The models simulate activation
and deactivation over physiological concentrations of Ca
2+,
diacyl glycerol (DAG), and PKCh using single and periodic
step increases. The model suggests the following: (1) the
activation NFAT does not occur at low frequencies as NFAT
requires calcineurin activated by Ca
2+ to remain dephos-
phorylated and in the nucleus; (2) NFjB is activated at lower
Ca
2+ oscillation frequencies than NFAT as IjB is degraded
in response to elevations in Ca
2+ allowing free NFjBt o
translocate into the nucleus; and (3) the degradation of IjBi s
essential for efﬁcient translocation of NFjB to the nucleus.
Through sensitivity analysis, the model also suggests that the
largest controlling factor for NFAT activation is the disso-
ciation/reassociation rate of the NFAT:calcineurin complex
and the translocation rate of the complex into the nucleus
and for NFjB is the degradation/resynthesis rate of IjB and
the import rate of IjB into the nucleus.
Keywords—Calcium, Computational model, T cell, Immune
response.
ABBREVIATIONS
NFAT nuclear factor of activated T cells
NFjB nuclear factor jB
PKC protein kinase C
DAG diacyl glycerol
IjB inhibitor for NFjB
IKK IjB kinase
C calcineurin
IL interleukin
TCR T cell receptor
Pi phosphate
INTRODUCTION
Nuclear factor of activated T cells (NFAT) and
nuclear factor jB (NFjB) are Ca
2+-dependent and
PKCh-dependent transcription factors that mediate the
immune response in T lymphocytes (T cells).
8,16,25,44,49
In resting cells both NFAT and NFjB reside primarily
in the cytoplasm, NFAT in its phosphorylated form
and NFjB bound to the inhibitor IjB. T cell receptor
stimulation initiates a cascade of intracellular reactions
causing an increase in the cytosolic calcium concen-
tration andaresulting translocation of both NFAT and
NFjB to the nucleus.
19,48 Both NFAT and NFjB may
bind to promoter regions of DNA and, in concert with
other transcription factors, allow expression of genes
responsible for the production of the interleukins IL-2
by NFAT
50 and IL-8 by NFjB.
58
In the NFAT pathway (Fig. 1a), Ca
2+ activates the
phosphatase calcineurin, which binds to and dephos-
phorylates NFAT.
34,45,59 Dephosphorylation exposes
nuclear localization signals,
10 resulting in rapid trans-
location of the NFAT-calcineurin complex to the
nucleus where it can participate in promoting gene
transcription.
51 The cytoplasm-to-nucleus transloca-
tion is opposed by kinases such as GSK-3 and possibly
protein kinase A that block the Ca
2+-calcineurin
dephosphorylation of NFAT in the cytoplasm, or that
rephosphorylate free NFAT in the nucleus.
9,43 Asso-
ciation of NFAT with activated calcineurin inhibits the
kinase activity; in the absence of activated calcineurin,
dephosphorylated NFAT in the nucleus is rephosph-
orylated and exported. This futile shuttling of NFAT
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1712into and out of the nucleus results in little gene
transcription, thus gene expression activated by NFAT
requires continuously active calcineurin.
54,62
In contrast to NFAT, NFjB is retained in the
cytoplasm (Fig. 1b) not by phosphorylation but by
association with the inhibitory IjB proteins.
7 In resting
cells, NFjB and IjB can dissociate in the cytoplasm
and translocate to the nucleus.
14 Reassociation of
NFjB and IjB masks nuclear localization signals on
both species resulting in nuclear export. NFjB has
little opportunity to bind to DNA during this shuttling
and so little transcription occurs. Stimulation of the T
cell receptor, however, initiates a cascade of reactions
proceeding through Ca
2+48 and PKCh
33,56 that results
in activation of the IjB kinase IKK. IKK phosphory-
lates IjB associated with NFjB, allowing the IjBt o
dissociate from NFjB and marking the IjB for sub-
sequent polyubiquitination and degradation by the
proteasome.
20,36 NFjB is freed by this degradation,
nuclearlocalizationsignalsonNFjBareexposed,andit
is translocated to the nucleus where it can bind to DNA
and promote gene transcription. IjB is resynthesized
when the calcium and PKCh concentration decrease.
Newly formed IjB translocates to the nucleus where it
binds to NFjB and masks its nuclear localization sig-
nals. The NFjB:IjB complex is then exported to the
cytoplasm thus completing the activation-deactivation
cycle. Recently, Hoffman and co-workers showed that
oscillations in the IjB concentration are observed
experimentally and modeled its mechanism.
26
In many cells, interplay of the sources and sinks of
Ca
2+ results in oscillations in the intracellular calcium
concentration when surface receptors are stimulated by
agonist.
11 In particular, T cells display calcium oscil-
lations in response to T cell receptor activation.
21 The
transcription factors NFAT and NFjB respond in
different ways to the frequency of these oscillations,
thus differentiating the activation of NFAT and
NFjB. In this way differential transcription factor
activation and consequent gene expression is conferred
through a ubiquitous second messenger, namely
Ca
2+.
22 Calcium oscillations have also been shown to
increase the level of NFAT activation at low levels of
stimulation over a steady rise in Ca
2+, increasing the
efﬁciency of low-level signal detection.
22 Furthermore,
overexpression of calcineurin partially replaces the
calcium requirement for NFAT activation, as does the
expression of constitutively active calcineurin.
39,15
Defects in the activation of NFAT and NFjB and
expression of IL-2 and IL-8, respectively, have been
implicated in a number of human diseases and condi-
tions. In several patients, failure to activate NFAT was
shown to cause severe combined immunodeﬁciency
disease, SCID.
23 Overexpression of IL-8 can cause
psoriasis and rheumatoid arthritis.
58 Other conditions
related to defects in NFAT and NFjB activation
include asthma, allergy, inﬂammation, and septic
shock.
These pathways also contain an important target for
drugs such as cyclosporin A and FK506, which act as
powerful immunosuppressants by blocking the acti-
vation of calcineurin’s phosphatase activity,
15,18,39
thereby suppressing activation of NFAT and NFjBi n
T cells. Furthermore, the PKCh inhibitor rottlerin can
block PKCh translocation to the immunological syn-
apse (IS),
57 which suppresses the activation of NFjBi n
T cells. These properties make these drugs useful not
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FIGURE 1. (a) Schematic diagram of the mechanism of ac-
tion of NFAT. At rest, NFAT is in its phosphorylated form
(NFAT:Pi) and located mainly in the cytosol. Upon activation,
a rise in [Ca]i activates calcineurin (C) which binds NFAT:Pi
and dephosphorylates it, allowing its import into the nucleus
where it can act on the DNA. (b) Schematic diagram of the
mechanism of action of NFjB. At rest, NFjB is bound to its
inhibitor IjB mainly in the cytosol (NFjB:IjB). Activation of
calcineurin (C) synergizes with PKCa activating an early
phase of the kinase IKK and activation of PKCh activates a
later phase of IKK which phosphorylates IjB. It then dissoci-
ates from NFjB allowing NFjB to be imported into the nucleus
where it can act on the DNA.
Control of Gene Expression 1713only in combating immune system diseases but also in
preventing the rejection of transplanted tissues. But the
general immune system suppression that results with
cyclosporin A and FK506 leads to severe side effects,
such as secondary tumors and opportunistic infec-
tions,
30 and progressive loss of renal function and
neurotoxicity.
5 Additionally, inhibition of transcrip-
tion factor activation in other types of cells can have
unintended and undesirable consequences.
1
To understand better how signal transduction
pathways function, to help ﬁnd therapies and cures for
immune system diseases, and to ﬁnd better ways to
control the immune system in transplant patients it
would be useful to understand the NFAT and NFjB
pathways in a quantitative fashion.
MODELS AND MECHANISMS
We have developed mathematical models for the
action of NFAT and NFjB that simulate the activation
and deactivation of each factor by changes in intracel-
lular calcium concentration. Two separate models have
been developed, one for NFAT and one for NFjB. We
required both models to incorporate experimentally
determined reaction pathways and to simulate activa-
tion and deactivation of the transcription factors
through experimentally determined intermediates and
over physiological calcium concentrations. Both mod-
els use parameters derived, as much as possible, from
experimental observations (Tables 1–4). We required
the models to be capable of simulating the system
response to calcium concentration oscillations and, in
line with experimental observations,
22 to show a dif-
ferent response in the activation of NFAT and NFjB
to changes in the frequency of the oscillations. We
expect the NFAT model to show that oscillations in the
concentration of calcium enhance the activity of NFAT
at low calcium concentrations and that overexpression
of calcineurin replaces the requirement for calcium
in the activation of NFAT. For both the NFAT and
NFjB models we expect the models to require
sustained calcium signaling for gene expression.
NFAT Model
A schematic diagram of the mechanism for the
action of NFAT is shown in Fig. 1b. A rise in the
cytosolic calcium concentration leads to an increased
calcium–calmodulin concentration which activates
calcineurin (denoted by C*). Calcineurin binds to and
dephosphorylates the cytosolic species NFAT:Pi, the
phosphorylated form of NFAT.
40,46 Without calmod-
ulin, the phosphatase activity of calcineurin is much
reduced.
31 The dephosphorylated NFAT-calcineurin
TABLE 1. NFAT rate constants.
Rate constant Value Source
k1 0.0000256 s
)1 Estimate
k2 0.00256 s
)1 Loh et al.
34
k3 0.005 s
)1 Estimate
k4 0.5 s
)1 Estimate
k5 0.0019 s
)1 Shibasaki et al.
52
k6 0.00092 s
)1 Shibasaki et al.
52
k7 0.005 s
)1 Estimate
k8 0.5 s
)1 Estimate
k9 0.5 s
)1 Estimate
k10 0.005 s
)1 Estimate
k11 6.63 lM
)1 s
)1 Adjusted to control rate of
activation observed
by Shaw et al.
51
k12 0.00168 s
)1 Adjusted to control rate of
deactivation observed
by Beals et al.
10
k13 0.5 s
)1 to agree with similar reactions
given by Klee et al.
32
k14 0.00256 s
)1 Loh et al.
34
k15 0.00168 s
)1 Adjusted to control rate of
deactivation observed
by Beals et al.
10
k16 6.63lM
)1s
)1 Adjusted to control rate of
activation observed
by Shaw et al.
51
k17 0.0015 s
)1 Zhu and McKeon
62
k18 0.00096 s
)1 Zhu and McKeon
62
k19 1.0lM
)3s
)1 Klee et al.
32; Kakalis et al.
29
k20 1.0 s
)1 Klee et al.
32, Kakalis et al.
29
k21 0.21 s
)1 Estimate and adjusted
relative to k22 to give
equal calcium ion
concentrations in nucleus
and cytoplasm
k22 0.5 s
)1 Estimate
TABLE 2. Concentration and volume parameters.
Parameter Value Source
Cell diameter 9000 nM Estimate
(Alberts et al.
2)
Nucleus diameter 6000 nM Estimate
(Alberts et al.
2)
Nucleus volume (vn) 113 lm
3 Calculated
Cytosol volume (vc) 269 lm
3 Calculated
Resting cell [Ca
2+] 100 nM Alberts et al.
2
Activated cell [Ca
2+] 1000 nM Alberts et al.
2
Total calcineurin
concentration
60.0 nM Crabtree
17
Total NFjB concentration 52.9 nM Carlotti et al.
13
Total NFAT concentration 7.23 nM Estimate
Total IjB concentration 55.0 nM Carlotti et al.
13
Number calcium ions
required to activate
each calcineurin molecule
3 Kakalis et al.
29
Total PKCh concentration 2000 nM Estimate
Total PKCa concentration 1000 nM Estimate
FISHER et al. 1714complex (NFAT:C
*) translocates to the nucleus, where
it may bind to promoter regions of DNA and assist in
initiation of gene transcription. A lowering of the
calcium concentration results in deactivation of calci-
neurin and its dissociation from the NFAT-calcineurin
complex. Free nuclear NFAT may then be phosphor-
ylated by ubiquitous kinases, masking nuclear locali-
zation signals and resulting in translocation from the
nucleus to the cytoplasm. Thus rising and falling cal-
cium ion concentrations result in activation and
deactivation of the transcription factor NFAT.
There are several simplifying assumptions made in
the model for NFAT activation: (1) the total cellular
concentration of NFAT remains constant, that is, the
degradation and synthesis rates are balanced; (2)
dephosphorylated NFAT bound to calcineurin in the
nucleus is the transcriptionally active form of NFAT;
(3) calcineurin dephosphorylates NFAT in one com-
posite dephosphorylation site (i.e. all sites are treated
as one); (4) The cytosolic and nuclear free calcium
concentrations are equal and are controlled by a cal-
cium clamp protocol simulating the procedure used by
TABLE 3. PKCa membrane-binding parameters.
Parameter Deﬁnition Value Source
KCa Dissociation constant 22.0 lM Nalefski et al.
38
h Calcium binding cooperativity 1.5 Nalefski et al.
38
n Stoichiometric coefﬁcient 2 mol/mol Nalefski et al.
38
KDAG Dissociation constant 10.2 nM Ananthanarayanan et al.
3
[DAG] Diacyl glycerol concentration 2000.0 nM Mogami et al.
37
tr2a IjB constitutive mRNA synthesis 1.54   10
)6 lMs
)1 Hoffmann et al.
25
tr2 IjB inducible mRNA synthesis 1.65   10
)2l M
)1 s
)1 Hoffmann et al.
25
tr3 IjB mRNA degradation 2.8   10
)4 s
)1 Hoffmann et al.
26
TABLE 4. NFjB rate constants.
Rate constant Value Source
k5 0.0019 s
)1 Shibasaki et al.
52
k6 0.00092 s
)1 Shibasaki et al.
52
k19 1.0lM
)3s
)1 Klee et al.
32; Kakalis et al.
29
k20 1.0 s
)1 Klee et al.
32, Kakalis et al.
29
k21 0.21 s
)1 Estimate and adjusted relative to k22 to give
equal calcium ion concentrations in nucleus
and cytoplasm
k22 0.5 s
)1 Estimate
k23 0.614 lM
)1 s
)1 Carlotti et al.
14, Huang et al.
27
k24 0.00184 s
)1 Carlotti et al.
14
k25 0.002 s
)1 Adjusted to control rate of activation/deactivation
observed by Dolmetsch et al.
22
k26 1.0 lM
)1 s
)1 Adjusted to control rate of activation/deactivation
observed by Dolmetsch et al.
22
k27 0.00026 s
)1 k28/k27 = 50; Carlotti et al.
14
k28 0. 0134 s
)1 Estimated from Birbach et al.
12
k29 0.010 s
)1 k30/k29 = 2, Carlotti et al.
14
k30 0.02 s
)1 Estimate
k31 0.000034 s
)1 Estimate
k32 0.000034 s
)1 Estimate
k33 0.02 s
)1 Estimate
k34 0.000034 s
)1 Estimate
k35 0.000000036 s
)1 Adjusted to agree with Trushin et al.
56
k36 0.00008 s
)1 Adjusted to agree with Trushin et al.
56
k37 0.0000016 s
)1 Adjusted to agree with Trushin et al.
56
k38 0.0008 s
)1 Adjusted to agree with Trushin et al.
56
k39 0.0016 s
)1 Adjusted to agree with Trushin et al.
56
k40 0.0006 s
)1 Adjusted to agree with Trushin et al.
56
k41 0.02 s
)1 Adjusted to agree with Yang et al.
60
k42 0.000177 s
)1 Adjusted to agree with Yang et al.
60
k43 0.02 Estimated from Trushin et al.
56
k44 0.009 Estimated from Trushin et al.
56
Control of Gene Expression 1715Dolmetsch et al.;
22 (5) calcineurin binds three calcium
ions to become active; and (6) NFAT and calcineurin
clearly bind to other molecules in the cell, however,
these interactions are ignored for simplicity.
A reaction scheme consistent with this mechanism is
given in Fig. 2a. Here nuclear species are shown in the
lower half of the ﬁgure and given the subscript n.
Cytosolic species are shown in the upper half of the
ﬁgure and given the subscript c. At the low calcium
concentrations present in the resting cell the dominant
NFAT-containing species is phosphorylated NFAT in
the cytoplasm, designated (NFAT:Pi)c (Fig. 2a – dark
gray box at left). At the high calcium concentrations
present in the activated cell the dominant species is
NFAT associated with activated calcineurin in the
nucleus, (NFAT:C*)n (Fig. 2a – light gray box at
right). The model treats cytosolic and nuclear entities
as distinct, and thus includes 12 separate chemical
species, and cytosolic and nuclear Ca
2+. The arrows
between species represent forward and reverse chemi-
cal reactions, or nuclear import and export. The rates
of reaction, and of import and export, are represented
by the 22 rate constants, designated k1 to k22.
Using the law of mass action, this reaction scheme
yields a system of 12 coupled ﬁrst order diﬀerential
equations describing the change in concentration with
time for each of the 12 distinct chemical species
(Appendix A). The parameters in the equations include
the 22 rate constants and the number of calcium ions
required to activate the phosphatase activity of each
(a)
(b)
FIGURE 2. (a) Reaction scheme for the NFAT mechanism. The activation path for NFAT is shown by the light gray arrows. An
increasing calcium concentration activates calcineurin (C), which binds to and dephosphorylates NFAT:Pi (dark gray box). The
NFAT-activated calcineurin complex NFAT:C* is imported to the nucleus where it may be transcriptionally active (light gray box).
The deactivation path for NFAT is shown by the dark gray arrows. A decreasing calcium concentration allows dissociation of NFAT
and activated calcineurin (NFAT:C*) in the nucleus (light gray box). Free NFAT is phosphorylated and exported to the cytoplasm
(dark gray box). (b) Reaction scheme for the NFjB mechanism. The activation path for NFjB is shown by light gray arrows. An
increase in the calcium ion concentration activates calcineurin in synergy with PKCa which, through a sequence of reactions,
activates an early phase of the kinase IKK. Activation of PKCh leads to activation of a later phase of IKK. IKK phosphorylates the
NFjB:IjB complex (dark gray box) which then dissociates. The phosphorylated IjB is degraded and the free NFjB imported into
the nucleus to be the transcriptionally active form (light gray). The deactivation path for NFjB is shown by dark gray arrows. A
decrease in the calcium ion concentration allows resynthesis of IjB:Pi, which enters the nucleus and associates with NFjB. The
resulting complex dephosphorylates and is exported from the nucleus.
FISHER et al. 1716calcineurin molecule, designated by m in the ﬁgure.
The time course for the concentrations of each of the
chemical species from a given initial condition is
determined by numerical solution of the system using a
standard fourth order Runge–Kutta technique.
Table 1 lists the rate constants used in the NFAT
model. They may be loosely divided into three groups:
(1) calculated from published data, (2) estimated from
published data, and (3) adjusted to fall within expected
physiological ranges in order to make the model con-
form to published experimental data.
NFkB Model
A schematic diagram of the mechanism of action of
NFjB is shown in Fig. 1b. As previous studies have
shown, PKCh and calcineurin act as co-activators of
the transcription factor NFjB.
55,56 A high calcium
concentration activates calcineurin and PKCa, which
through a sequence of reactions, co-activates the IKK
complex with PKCh. TCR/CD3 activation leads to the
translocation of PKCh to the immunological synapse
(IS), and CD28 activation leads to PKCh migration to
the central supramolecular activation cluster (cSMAC)
in the IS.
28 IKK phosphorylates IjB in the complex
NFjB:IjB, leading to immediate recognition of IjBb y
the F-box/WD-domain protein E3RS,
IjB61 polyubiq-
uitination of the IjB
20 and subsequent degradation of
the IjB by the proteasome. Our model does not
explicitly include the polyubiquitination but includes it
in the degradation rate of IjB which is essential for
NFjB translocation and hence for gene transcription.
Once freed of IjB, NFjB translocates to the nucleus
where it may bind to DNA and promote gene tran-
scription. When the calcium concentration falls to
resting levels, newly synthesized IjB rapidly translo-
cates to the nucleus where it combines with NFjB,
masking nuclear localization signals on both species.
6
The NFjB:IjB complex is then exported from the
nucleus to the cytoplasm.
There are several simplifying assumptions used to
render the model computationally tractable: (1) the
total cellular NFjB concentration is constant due to a
balance between its synthesis and degradation pro-
cesses; (2) IjB production is enhanced by activated
NFjB as described by Hoﬀman et al.;
26 (3) the cyto-
solic and nuclear free calcium concentrations are equal
and are controlled by a calcium clamp protocol sim-
ulating the procedure used by Dolmetsch et al.;
22 (4)
the IKK kinases are lumped into one reaction; (5) in
the model IjB represents IjBa; (6) the amount of free
NFjB in the nucleus is used as a measure of the acti-
vation of the transcription factor; (7) calcineurin binds
3 calcium ions to become active; and (8) the binding of
calcineurin, IjB, and NFjB to other molecules in the
cell clearly occurs, but is not included in the model for
simplicity.
A reaction scheme consistent with this schematic
diagram is shown in Fig. 2b. As in the reaction scheme
for NFAT, nuclear species are shown in the lower half
of the ﬁgure and given the subscript n. Cytosolic spe-
cies are shown in the upper half of the ﬁgure and given
the subscript c. In the resting cell, the dominant NFjB
containing species is NFjB:IjB in the cytoplasm
(Fig. 2b – dark gray box at right). In the active cell, the
dominant species is NFjBn (Fig. 2b – light gray box at
left). The NFjB model has 17 different chemical spe-
cies with the nuclear and cytosolic concentrations
represented separately. As in the NFAT model, the
arrows between species represent forward and reverse
chemical reactions, or nuclear import and export. The
rates of reaction, and of import and export, are rep-
resented by the 26 rate constants, designated k5 and k6
and k19 to k42. Note that k41 represents the rate of
degradation of IjB and k42 the rate of its resynthesis.
26
From the NFjB reaction scheme a system of 17 cou-
pled ﬁrst order differential equations may be written,
one for the change in concentration with time of each
of the 17 distinct chemical species (Appendix B). Given
the initial concentration of each species, numerical
integration of the system yields the time course of the
concentration for each species.
RESULTS AND DISCUSSION
A number of simulations were performed to dupli-
cate experimental results to validate the model. In all
simulations, the parameters listed in Tables 1–4 were
used unless stated in the ﬁgure legends. The only dif-
ference in the simulated results was the calcium clamp
protocol used.
NFAT Model Results
Using the parameter values in Tables 1 and 2, the
model was allowed to come to steady state at rest
([Ca]i = 0.1lM). The resting state concentrations are
shown in Table 5. These concentrations were used as
initial values when simulating the evolution of the
concentration of each species during a transition from
the resting state ([Ca]i = 0.1 lM) to the active state
([Ca]i = 1.0 lM). The results areshowninFig. 3a.The
high calcium concentration activates calcineurin, which
associates with and dephosphorylates NFAT:Pi in the
cytoplasm; the concentration of NFAT:Pi in the cyto-
plasm falls rapidly. Only a small amount of NFAT:-
Pi:C* is formed in the cytoplasm when activated
calcineurin associates with NFAT:Pi because it is rap-
idly dephosphorylated to NFAT:C*, which in turn is
Control of Gene Expression 1717rapidly translocated to the nucleus where it is trans-
criptionally active. Note in this ﬁgure that the change in
concentration of the nuclear species appears large rel-
ative to the concentrations of the cytosolic species
because the volume of the nucleus is smaller than the
volume of the cytoplasm by a factor of about 2.4. The
light gray arrows in Fig. 2a show the NFAT activation
pathwayonthereactionschemeforNFAT.Calcineurin
associates with calcium ion, activating calcineurin. The
activated calcineurin associates with phosphorylated
NFAT and dephosphorylates it. The NFAT:C* result-
ing from this dephosphorylation is rapidly imported to
the nucleus where it is transcriptionally active.
A simulation of the deactivation of the activated
state is shown in Fig. 3b. Here the initial concentra-
tions were those of the activated steady state, and the
calcium ion concentration was set to 0.1 lM. Fig-
ure 3b shows that the concentration of the transcrip-
tionally active species (NFAT:C*)n falls rapidly as
NFAT and calcineurin dissociate. Consequently the
concentration of NFATn rises as NFAT is freed by
the dissociation, and then falls as it is phosphorylated.
The concentration of the phosphorylated species
(NFAT:Pi)n never rises very high because this species is
rapidly exported from the nucleus. The dark gray ar-
rows in Fig. 2a show the NFAT deactivation pathway
on the reaction scheme for NFAT. After (NFAT:C*)n
dissociates, free NFAT is phosphorylated and ex-
ported from the nucleus.
Dolmetsch et al.
22 suggest that non-linearity in the
response of NFAT to calcium ion concentration is
important in determining how the activity of NFAT
depends on oscillations in the calcium ion concentra-
tion. Their experiments show that oscillation frequency
is the critical factor in differentiating the response of
NFAT and NFjB. Our models for both NFAT and
NFjB simulate the effect of calcium ion concentration
oscillations on the activation of the transcription fac-
tors. One such simulation for NFAT is shown in
Fig. 4a. The initial concentrations of the species were
those of the resting state and the oscillation period of
the calcium ion concentration was 100 s. The calcium
ion concentration was ﬁxed at 1.0 lM during the ini-
tial 10 s and 0.1 lM during the ﬁnal 90 s of each
oscillation. Figure 4a shows that the concentration of
the transcriptionally active (NFAT:C*)n rises rapidly
during the high calcium concentration pulse and then
decays more slowly during the low calcium concen-
tration portion of the period. The concentration of
(NFAT:Pi)c follows the reverse trend, decreasing rap-
idly when the calcium ion concentration is high and
increasing slowly when the concentration is low. A
fraction of the NFAT exists as free NFAT in the nu-
cleus, oscillating between the form NFATn and
(NFAT:C*)n as calcineurin associates with and disso-
ciates from NFAT. We can easily see that in the ab-
sence of constant signaling the concentration of
transcriptionally active (NFAT:C*)n would soon fall
to resting state levels. This is shown in Fig. 4a where at
1500 s the calcium ion concentration is set to 0.1 lM.
The concentration of the transcriptionally active
(NFAT:C*)n falls and that of (NFAT:Pi)c rises, both
approaching their resting levels as time increases.
TABLE 5. NFAT resting steady-state concentrations.
Species Concentration (nM)
NFATn 0.5219
NFATc 0.1101
C*n 0.0505
C*c 0.0091
(NFAT:Pi)n 0.2272
(NFAT:Pi)c 9.4397
(NFAT:Pi:C*)n 0.0025
(NFAT:Pi:C*)c 0.0022
(NFAT:C*)n 0.9477
(NFAT:C*)c 0.0061
Cn 49.198
Cc 9.7108
Can
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FIGURE 3. (a) Activation of NFAT from the resting state. (b)
Deactivation of NFAT from the active state. The reaction paths
(Fig. 2a) for the activation and deactivation of NFAT are
determined by observing the sequence of the formation of the
various species in the reaction scheme.
FISHER et al. 1718To study how the degree of NFAT activation varies
with oscillation frequency, we simulated calcium con-
centration oscillations using 10 s intervals of high
concentration and varying intervals of low concentra-
tion, with the total period ranging from 100 to 1800 s
(Fig. 4b). Because the concentration of the transcrip-
tionally active (NFAT:C*)n varies throughout the
period, a sufﬁcient number of periods was simulated to
reach a stable state, then the lowest value of
(NFAT:C*)n during the last period was chosen to
calculate the percent of NFAT in the transcriptionally
active form. We reasoned here that NFAT involved in
shuttling in and out of the active form was not likely to
bind to DNA and assist in initiation of transcription,
thus the lowest value of the concentration of the active
form was justiﬁed. In this way the fraction of NFAT in
the transcriptionally active form was found as a func-
tion of the oscillation period. Figure 4b shows that the
percent of NFAT that is transcriptionally active is al-
most 60% with a 100 s period, and that this fraction
falls to less than 10% with a 900 s period. These results
agree qualitatively with the results presented by Dol-
metsch et al.,
22 in their Fig. 3b for the percent of gene
expression as a function of oscillation period. Their
data shows 50% gene expression with a 100 s oscilla-
tion, with the percent expression falling to zero for
periods of 400 s or more. The quantitative differences
between our simulated results and the experimental
observations by Dolmetsch et al.
22 possibly occur be-
cause they have determined percent gene expression
while we calculate percent of NFAT that is transcrip-
tionally active. There might be additional non-linearity
or cooperativity introduced in transcription factor
binding to DNA and transcription. For example, as
mentioned earlier, Fiering et al.
24 observed that the
binding of 3 NFAT molecules to a constructed pro-
moter on a DNA strand produced cooperativity of
transcription. They also suggested a similar require-
ment for NFjB activation of gene expression. While
inclusion of these factors would result in a more
quantitatively accurate reproduction of the reporter
gene expression data, we chose to simplify the model to
emphasize the mechanisms for activation of the tran-
scription factors.
Dolmetsch et al.
22 show that the percent of cells
expressing a lacZ+ reporter gene, sensitive to trans-
criptionally active NFAT, decreased when the steady-
state calcium concentration fell below about 0.35 lM.
But if the calcium concentration exhibited oscillations,
the gene expression persisted to an average calcium
concentration at least as low as 0.2 lM. The model
displays similar behavior (Fig. 4c). To simulate oscil-
lations, 10 s periods of high calcium concentration and
90 s periods of low calcium concentration were used.
The low calcium concentration was ﬁxed at 0.1 lM,
and the concentration during the high calcium inter-
vals was ﬁxed in each of several tests to produce a set
of experiments each having a different average calcium
concentration. Model data for the steady state was
obtained following the protocol described previously.
Figure 4c shows that simulating oscillations does
indeed enhance the activity of NFAT at low calcium
0
0.01
0.02
0.03
0 1000 2000 3000
time (sec)
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
u
M
)
period = 100 sec
(NFAT:C*)n
NFATn
(NFAT:Pi)c
activation deactivation
0
10
20
30
40
50
60
0 500 1000 1500 2000
period (sec)
p
e
r
c
e
n
t
 
a
c
t
i
v
e
 
N
F
A
T
0
20
40
60
80
100
0.1 0.2 0.3 0.4 0.5
average calcium concentration (µM)
p
e
r
c
e
n
t
 
a
c
t
i
v
e
 
N
F
A
T oscillating
[Ca2+]
constant 
[Ca2+]
(a)
(b)
(c)
FIGURE 4. (a) Activation of NFAT by oscillations in the cal-
cium ion concentration. During each period the calcium con-
centration was high (1.0 lM) for 10 s and low (0.1lM) for 90 s.
At 1500 s the calcium concentration was set to the resting
state value (0.1 lM) and the system returned to the resting
state. (b) The percent of NFAT in the active state is plotted as a
function of calcium ion oscillation period. (c) The percent of
NFAT in the active state is plotted as a function of average
calcium ion concentration for steady state and oscillating
calcium ion concentrations. The percent of NFAT in the active
steady state decreases below 0.4 lM when the calcium con-
centration is constant. The percent of NFAT in the active state
persists at a high level to less than 0.2 lM average concen-
tration when the calcium concentration oscillates.
Control of Gene Expression 1719concentrations relative to the activity at a constant
calcium concentration. The shape of the curves repre-
senting steady state and oscillating calcium concen-
tration behavior are quite similar to those shown by
Dolmetsch et al.,
22 in their Fig. 2c. The two calculated
curves meet at a calcium concentration of 0.39 lM,
very close to the 0.35 lM shown in the experimental
work. This corresponds to a period of approximately
30 s. If the period is longer than 30 s (the average
calcium is lower than 0.39 lM), then the oscillations
are more potent than steady-state calcium with the
same average at activating NFAT. If higher, the
opposite is true. The model data shows enhanced
NFAT activity down to about 0.2 lM, below which
the activity decreases rapidly.
Finally, the NFAT model was tested to determine if
it correctly simulates the observation that overexpres-
sion of calcineurin partially replaces the requirement
for calcium, as reported by Luo et al.
35 These simula-
tions were carried out by holding the calcium ion
concentration ﬁxed at the resting state value, 0.1 lM,
and varying the calcineurin concentration, followed by
calculating the degree of activation of the NFAT.
Figure 5 shows the results obtained when the calci-
neurin concentration was increased as much as a factor
of 25 times above the baseline concentration. The
percent of NFAT in the transcriptionally active form
does indeed increase when the calcineurin concentra-
tion increases, and high levels of activation are
achieved with high calcineurin concentrations.
NFjB Model Results
The NFjB model was characterized in a manner
similar to that for the NFAT model. Using the
parameters from Tables 2–4, the calcium concentration
was ﬁxed at 0.1 lM and the time evolution of the
concentration of each species calculated until steady
state values were observed. These concentrations were
taken to be those of the steady state at rest (Table 6).
Figure 6a shows the concentrations of species in the
NFjB model during a transition from the resting to
active states. Starting with the resting steady state
concentrations, the calcium ion concentration was
ﬁxed at 1.0 lM and the time evolution of the concen-
tration of each species calculated. The high calcium
concentration activates calcineurin, which in synergy
with PKCa and PKCh, co-activates the kinase IKK.
The activated kinase phosphorylates IjB associated
with NFjB in the cytoplasm. Subsequent polyubiqui-
tination and IjB degradation result in a decrease in the
cytoplasmic NFjB:IjB:Pi concentration, a dissocia-
tion of NFjBa n dI jB, and rapid translocation of
NFjB into the nucleus. The concentration of cytosolic
NFjB never rises very high because of its rapid nuclear
import, therefore the concentration of this species is
not shown in Fig. 6a. The light gray arrows in Fig.2b
show the NFjB activation pathway on the reaction
scheme for NFjB. A rise in the calcium concentration
activates calcineurin, which through a sequence of
reactions, and in synergy with PKCa, activates an
early phase of the kinase IKK. CD3/CD28 activate
PKCh, leading to activation of a later phase of IKK.
57
Activated IKK phosphorylates the NFjB:IjB complex
in the cytoplasm. After dissociation, the phosphory-
lated IjB is polyubiquitinated and degraded, and free
NFjB is imported to the nucleus where it may be
transcriptionally active.
Deactivation of the activated state of NFjBi s
shown in Fig. 6b. The initial concentrations were those
of the activated state at equilibrium, and the calcium
ion concentration was ﬁxed at 0.1 lM. The most
important step in deactivation is synthesis of new IjB,
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FIGURE 5. Percent active NFAT as a function of calcineurin
concentration at ﬁxed low calcium ion concentration. The
calcium concentration was ﬁxed at a level characteristic of the
resting state (0.1 lM) and the calcineurin concentration
increased to simulate overexpression of calcineurin. Each
data point shows the steady state concentration of trans-
criptionally active NFAT at a ﬁxed calcineurin concentration.
Overexpression of calcineurin replaces the requirement for
calcium at ﬁxed low calcium concentration.
TABLE 6. NFjB resting steady-state concentrations.
Species
Concentration
(nM)
NFjBn 7.1779
NFjBc 0.0731
(IjB:Pi)n 0.2035
(IjB:Pi)c 0.0525
(NFjB:IjB:Pi)n 0.2343
(NFjB:IjB:Pi)c 0.1076
(NFjB:IjB)n 0.2376
(NFjB:IjB)c 52.961
C*n 0.0505
C*c 0.0091
Cn 49.198
Cc 9.7108
Ca
2þ
n 100
Ca
2þ
c 100
FISHER et al. 1720which is rapidly translocated to the nucleus forming
the phosphorylated complex with NFjB. This complex
is dephosphorylated and rapidly translocated into the
cytoplasm. The result is an overall increase in con-
centration of NFjB:IjB in the cytoplasm as the con-
centration of NFjB in the nucleus decreases. The dark
gray arrows in Fig. 2b show the pathway for deacti-
vation on the reaction scheme for NFjB. Newly syn-
thesized IjB is imported to the nucleus where it
associates with NFjB. The resulting complex dep-
hosphorylates, and the NFjB:IjB complex is exported
to the cytoplasm. As for NFAT, Dolmetsch et al.,
22
have studied the degree of gene expression caused by
NFjB as a function of steady-state calcium ion con-
centration. In their paper, Fig. 3a shows that NFAT
and NFjB behave in a similar manner; they exhibit a
highly non-linear sigmoidal dependence, with very lit-
tle gene expression at calcium ion concentrations of
0.1 lM or less, a rapid rise in gene expression at cal-
cium concentrations between 0.1 lM and 0.5 lM, and
near 100% gene expression at calcium concentrations
over 0.5 lM. Since we follow the calcium clamp pro-
tocols used by Dolmetsch and co-workers, which does
not involve CD3 or CD28 activation and hence does
not involve activation of PKCh, we do not activate
PKCh in these simulations. Figure 7 shows our simu-
lated results for NFjB without PKCh activation, with
the percent of NFjB that is transcriptionally active
plotted as a function of the calcium ion concentration.
These results were obtained by setting the calcium ion
concentration to the desired value, then calculating the
concentration of transcriptionally active NFjBa sa
function of time until a steady state was reached. There
is good agreement between our simulated behavior and
the experimental results of Dolmetsch et al.
22 Both
show activation of NFjB over the physiological range
of calcium ion concentrations, with little activity at low
concentrations and full activity at high concentrations.
The sigmoidal shape of the calculated curve agrees
with the experimental results.
As was done for the NFAT model, the NFjB model
will simulate the system response to calcium oscilla-
tions. An example of NFjB activation by calcium
concentration oscillations is shown in Fig. 8a. The
initial concentrations were those of the resting steady
state and the oscillation period was 100 s. The calcium
ion concentration was ﬁxed at 1.0 lM during the
initial 10 s of each period and at 0.1 lM for the
remaining 90 s of each period. When the calcium
concentration is high, the concentration of NFjB:IjB
in the cytoplasm falls rapidly, and when the calcium
concentration is low the concentration of this species
increases slowly. The concentration of NFjB in the
nucleus follows the reverse trend, increasing rapidly
during the periods of high calcium concentration and
falling more slowly when calcium concentration is low.
During the calcium oscillations, the concentration
of the transcriptionally active nuclear NFjB rises,
showing little oscillation because of the relatively slow
rate of the polyubiquitination and IjB degradation
steps. In the absence of constant signaling the con-
centrations of the species return to their resting levels.
In Fig. 8a the concentration of Ca
2+ is set to 0.1lMa t
2000 s, after which the concentration of nuclear NFjB
falls, and that of (NFjB:IjB)c rises, to levels charac-
teristic of the resting state.
We studied how the degree of NFjB activation var-
ied with calcium concentration oscillation period as we
did for the NFAT model. Figure 8bshows the results of
simulations with periods varying from 100 to 2000 s.
For the shortest period, the percent of active NFjB was
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FIGURE 6. (a) Activation of NFB from the resting state. (b)
Deactivation of NFB from the active state. The sequence of
events depicted in Fig. 2b can be determined by observing the
time evolution of the concentration of the different reaction
species.
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FIGURE 7. Dependence of the percent active NFB on the
steady-state calcium concentration. For each data point the
calcium ion concentration was ﬁxed at the indicated value.
Control of Gene Expression 172170%, and at the longest period the percent active NFjB
was 20%. These results agree qualitatively with those
shown by Dolmetsch et al.,
22 in their Fig. 3b. Their
ﬁgure shows over 90% gene expression with a 100 s
period, falling to less than 20% gene expression for an
1800 s period. Note that they have determined percent
gene expression while we calculate percent of trans-
criptionally active NFjB, a difference that may explain
the quantitative difference in the results.
Figure 8b combines the model results for NFAT
and NFjB to compare the effect of oscillation fre-
quency on activation of NFjB to the activation of
NFAT by including the curve from Fig. 4b. Figure 8b
shows that a higher fraction of the NFjB is trans-
criptionally active than that of NFAT for long oscil-
lation periods. These results agree qualitatively with
those shown in Dolmetsch et al.,
22 Fig. 3b, where gene
expression by NFAT declined rapidly with oscillation
frequency but persisted to long periods for NFjB.
Figure 9a simulates the results of Yang et al.,
60 who
studied the degradation of IjBa with time in ﬁbro-
blasts. To simulate this, we have used Ca
2+ oscillations
with a period of 100 s and assumed that degradation is
the same for all members of the IjB family and then
plotted the percent of IjB remaining with time. We
have also assumed that the active PKCh and PKCa
concentrations drop after 30 min based on the experi-
mental observations of Szamel et al.
53 who report that
PKCh and PKCa translocated rapidlyto the membrane
within 1–10 min and start to decline after 30 min. This
was simulated with the model by reducing the amounts
of active PKCh and PKCa concentrations to resting
values at 40 min (Fig. 9a). The simulation shows that
there is near complete degradation of IjB in about
30 min, which agrees with the experimental results
shown in Yang et al.
60 in their Fig. 2. They observed an
increase in IjB concentration after about 40 min.
Figure 9b shows that the rate of degradation of IjB
is an essential factor in the activation of NFjB. Here
the dependence of the percent active NFjB is shown as
a function of the IjB constitutive degradation rate, k41
in the NFjB model. Our NFjB model uses a degra-
dation rate of 0.02 s
)1. As the degradation rate
decreases below this value the percent of active NFjB
decreases, thus a sufﬁciently high IjB degradation rate
is required for efﬁcient NFjB activation.
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FIGURE 8. (a) Activation of NFB by oscillations in the cal-
cium ion concentration. During each period the calcium con-
centration was high (1.0 lM) for 10 s and low (0.1 lM) for 90 s.
The concentration of the NFB:IB complex in the cytoplasm
falls rapidly during periods of high calcium concentration.
The concentration of the phosphorylated NFB:IB complex
ﬁrst rises, then falls as IB is degraded. Free NFB is imported
to the nucleus, steadily increasing the concentration of the
transcriptionally active nuclear NFB. (b) Differentiation of the
activity of NFAT and NFB by calcium ion oscillation period.
The activity of NFB decreases as the oscillation period in-
creases (upper curve) but not as much as for NFAT (lower
curve); the percent active NFB is greater than that of NFAT
for a given calcium concentration oscillation period. This
dissimilarity in behavior differentiates the response of NFAT
and NFB to calcium concentration oscillations.
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high to obtain signiﬁcant activation of NFB. The NFB model
uses a degradation rate of 0.02 s
)1.
FISHER et al. 1722SENSITIVITY ANALYSIS
To further characterize the system, a sensitivity
analysis was performed to determine which steps in the
reaction schemes for NFAT and NFjB exerted the
most inﬂuence on the activation of the transcription
factors. To this end, each rate constant was increased
and decreased by 10%. The percent change of steady-
state active transcription factor at 1.0 lM calcium over
the control was calculated (Fig. 10). The sensitivity
was calculated by
ln
active transcription factor atþ10% ðÞ
active transcription factor at 10% ðÞ
rate constant times 1.1 ðÞ
rate constant times 0.9 ðÞ
ForNFAT(Fig. 10a),therateconstantsthatseemto
exertthegreatesteffectonactivationarek9,k10,k13,k14,
k15, k16, k19, and k20. The rate constants k9 and k10
control the rate of nuclear import and export of NFAT
and the rate constants k13 and k14 control the phos-
phorylation and dephosphorylation of NFAT by calci-
neurin. The sensitivities here suggest that increasing the
binding afﬁnity of NFAT and calcineurin (k15 and k16)
willincreaseactivationofNFAT.Thisisconsistentwith
mutational studies that demonstrate that alteration of
the calcineurin binding site on NFAT decreases activa-
tion of NFAT.
4,41 It is interesting to note that even
though the sensitivities of NFAT activation to changes
ink11andk12areintheexpecteddirections,thevaluesof
these sensitivities are relatively small. Also, increasing
the rate of activation of calcineurin through calcium
binding (k19 and k20) will also increase activation of
NFAT. Other rate constants that exert a small but still
signiﬁcanteffectarek5andk6suggestingthatanincrease
in the amount of free cytosolic calcineurin will increase
activation of NFAT. This is consistent with Fig. 5
and the experiments that demonstrate that increasing
calcineurin increases the activation of NFAT.
For NFjB (Fig. 10b), the rate constants k30, k41, k42
and tr3 exert the greatest control on the activation of
NFjB. The rate constants k23, k24, k25, k26, k27, k28, k43
k44, tr2 and tr2a also exert a signiﬁcant inﬂuence on
activation of NFjB. The rate constants k41 and k42
control the degradation and synthesis of IjB. The rate
constants tr2, tr2a and tr3 control the rate of IjB
mRNA synthesis and degradation. The importance of
these rate constants re-emphasizes the importance of
the removal of free IjB from the cystosol for activation
of NFjB as indicated by Fig. 9. The rate constants k43
and k44 control the shuttling of IKK between the
cytoplasm and the nucleus. The rate constants k30 and
k29 control the import of IjB into the nucleus. Pre-
venting the import of IjB into the nucleus increases the
activation of NFjB as it lowers the amount of IjB
available to bind NFjB which leads to its export from
the nucleus. The rate constants k23 and k24 control the
dissociation of NFjB and IjB. Increasing the disso-
ciation rate increases activation of NFjB. The effect of
the rate constants k25 and k26 demonstrate that
increasing the rate of phosphorylation of IjB by IKK
increases the activation of NFjB. Finally, decreasing
k27, the rate constant for export of NFjB out of the
nucleus, or increasing k28, the rate of import NFjBt o
the nucleus, increases the amount of activation of
NFjB. This effectively increases the amount of NFjB
in the nucleus. It is interesting that although reducing
the rate of phosphorylation of IKK by calcineurin does
inhibit NFkB translocation to the nucleus, this is not
one of the most sensitive parameters. The sensitivity
analysis suggests that there are several other targets
that will block NFAT and NFjB translocation. For
several of the targets on NFAT, there is experimental
data to support the model predictions about the sen-
sitivities. On the other hand, the prediction that
blocking of NFAT translocation decreases transcrip-
tion has yet to be veriﬁed experimentally. This might
be accomplished by developing a compound that either
binds the nuclear import site of NFAT or that blocks
the import mechanism. For NFjB the prediction of
this analysis is that the most effective target would be
to block IjB degradation or increase its re-synthesis.
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FIGURE 10. (a) Sensitivity analysis for NFAT activation. (b)
Sensitivity analysis for NFB activation. In both cases, the
rate constants were increased and decreased by 10%. The
sensitivity of the steady state concentration of active tran-
scription factor at 1.0 lM calcium to changes in the rate
constants is shown.
Control of Gene Expression 1723Another potent target would be to block NFjB
translocation. Other possible interventions to block
NFjB translocation would be to introduce compounds
that increase the afﬁnity of NFjB for IjB or that
increase the activity of IKK. These are not the only
possible sites as many accessory pathways regulate this
system. Future studies that build on this model and
explore these pathways will give further insight.
CONCLUSIONS
We have developed models for the calcium and
PKCh mediated activation and deactivation of the
transcription factors NFAT and NFjB that incorpo-
rate experimentally determined reaction pathways and
that simulate this action over physiological calcium
concentrations. The model reproduces experimentally
observed behaviors of both the NFAT and NFjB
systems under a variety of conditions.
Several parameters values for T cells were not
available and therefore were derived from experimen-
tal observations in cells other than the T cell. For the
most part these choices are reasonable estimates, but
should be examined further as new data on signaling
during T cell activation becomes available. Variations
in some estimates will have a greater inﬂuence on
model outcomes than the others. For example, the
total concentration of NFjB was taken from ﬁbroblast
data,
13 but this mostly affects the amount activated
rather than the percent activated yielding a small
control coefﬁcient (0.0127). On the other hand, sensi-
tivity analysis indicates that the degradation rate of
IjB that was estimated using data from ﬁbroblasts
60
would exert a greater inﬂuence on model results and
thus its choice is more critical.
While the model is qualitatively accurate, simulation
of the reporter gene levels observed by Dolmetsch and
colleagues might be more closely approximated by the
inclusion of additional features to the model. Several of
these enhancements are obvious and consist of includ-
ing elements both upstream and downstream of the
system modeled. For example, binding of the tran-
scription factorstotheDNA might beaddedalong with
steps to describe the expression of the reporter genes
observed in the experiment. Inclusion of these steps
would require adding signiﬁcant complexity to the
model that might obstruct demonstration of the mech-
anisms governing activation of the calcium dependent
transcription factors NFAT and NFjB. Thus, addition
of these steps has been left for future work.
Although this model is able to simulate the calcium
clamp in the in vitro experiments used by Dolmetsch
and co-workers, in vivo the T cell has more complex
calcium dynamics. One aspect of these dynamics is the
calcium activation of PKC and its feedback on phos-
pholipase C (PLC). Many studies have indicated that
PKC acts as a co-activator of the transcription factors
NFAT and NFjB through its effect on calcineurin.
18,55
According to Pfeifhofer et al.,
42 PKCh is predomi-
nately expressed in T-lymphocytes. They found that
PKCh increases NFAT and NF-jB activation by
reducing the intracellular calcium elevation through a
reduction in IP3 production. They also found that
PKCa does this to a lesser degree. The current model
includes the activation of PKCh and its effect on
IKK complex. Future work might include any feedback
of PKC on PLC and possibly the actions of other
PKCs.
47
Two computational models have been developed by
other authors to model the dynamics of NFjBi nT -
lymphocytes. The model developed by Carlotti et al.,
13
describes the association and dissociation of NFjBa n d
IjB and their translocation into the nucleus both in the
associated and dissociated forms. Their model
demonstrates that NFjB is localized in the cytoplasm
at rest due to its association with IjB and the export
of NFjB from the nucleus. A second model, developed
by Hoffman and co-workers, demonstrated that
the emporal control was due to coordinated degrada-
tion and resynthesis of IjB and that IjB provides a
strong negative feedback that can turn off the NFjB
response.
APPENDIX A – NFAT MODEL EQUATIONS
d½NFATn 
dt
¼k1½ðNFAT:PÞn  k2½NFATn 
þ k17½NFAT 
vc
vn
  k18½NFATn 
þ k15½ðNFAT:CÞn  k16½NFATn ½C
 
n 
d½NFATc 
dt
¼k1½ðNFAT:PiÞc  k2½NFATc 
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d½C
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APPENDIX B – NFjB MODEL EQUATIONS
d½NFjB n
dt
¼ k27[NFjBn þk28[NFjBc 
vc
vn
  k23[NFjBn ½IjBn 
þ k24½ðNFjB : IjB : PiÞn 
d½NFjB c
dt
¼ k28[NFjBc þk27[NFjBn 
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